| P50 | author | Steven Rosenberg | Q2347448 |
| | Ken-Ichi Hanada | Q71142559 |
| P2093 | author name string | James C Yang | |
| | John R Wunderlich | |
| | Takashi Inozume | |
| | Qiong J Wang | |
| | Mojgan Ahmadzadeh | |
| P2860 | cites work | GM-CSF/IL-3/IL-5 receptor common beta chain (CD131) expression as a biomarker of antigen-stimulated CD8+ T cells | Q36580172 |
| | Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity | Q36693023 |
| | Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy | Q36718954 |
| | Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma | Q39888328 |
| | Generating renal cancer-reactive T cells using dendritic cells (DCs) to present autologous tumor. | Q40362192 |
| | Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer. | Q54287306 |
| | Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death | Q24293504 |
| | CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms | Q24534904 |
| | Adoptive immunotherapy for cancer: building on success | Q24546258 |
| | Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens | Q24644442 |
| | Adoptive cell transfer: a clinical path to effective cancer immunotherapy | Q24644774 |
| | Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation | Q24675931 |
| | Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer | Q24685406 |
| | Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion | Q28131654 |
| | Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor | Q28144319 |
| | Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice | Q28201627 |
| | Restoring function in exhausted CD8 T cells during chronic viral infection | Q28289222 |
| | PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression | Q29618956 |
| | Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired | Q34080914 |
| | Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction | Q34570127 |
| | Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy | Q34823783 |
| | Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities | Q35850673 |
| | Adoptive cell therapy for the treatment of patients with metastatic melanoma | Q36283034 |
| | Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients | Q36551911 |
| P433 | issue | 9 | |
| P304 | page(s) | 956-964 | |
| P577 | publication date | 2010-11-01 | |
| P1433 | published in | Journal of Immunotherapy | Q15763946 |
| P1476 | title | Selection of CD8+PD-1+ lymphocytes in fresh human melanomas enriches for tumor-reactive T cells | |
| P478 | volume | 33 | |